AZN · AstraZeneca
Latest news, signals, and AI analysis for AstraZeneca (AZN) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent AZN News
FDA extends review period for AstraZeneca’s camizestrant breast cancer application
FDA delays ruling on AstraZeneca drug after negative adcomm vote - Fierce Biotech
US regulator delays decision on AstraZeneca cancer drug - Financial Times
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo NordiskFrequently Asked Questions
What sector does AZN belong to?
AZN (AstraZeneca) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time AZN news?
Catalayer aggregates AZN coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/AZN.
How fast are AZN news alerts on Catalayer?
News is polled every 30–60 seconds. AZN-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for AZN?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every AZN story.
Is AZN covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support AZN. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.